Raloxifene suppresses growth and promotes intrinsic apoptotic signaling in C6 glioma cells
Naunyn-Schmiedeberg's Archives of Pharmacology · 07.08.2026
DOI: 10.1007/s00210-026-05792-x ↗Kurz gefasst
Fachartikel in der Zeitschrift Naunyn-Schmiedeberg's Archives of Pharmacology, online erschienen am 07.08.2026. Verfasst von Mahtab Roustaei und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Toxicology, TeMS.C., Islamic Azad University, Tehran, Iran. Die Arbeit nennt 53 Literaturangaben.
Abstract (Originalsprache)
Glioblastoma (GBM), the most common malignant brain tumor, remains highly resistant to current standard treatments, highlighting the urgent need for novel treatment strategies. Epidemiological evidence shows a lower incidence rate of GBM in women than in men, suggesting a potential protective role of estrogen. Given that GBM cells disturb cell cycle regulation through uncontrolled proliferation, targeting apoptotic pathways has emerged as a promising therapeutic approach. Raloxifene (RAL), a selective estrogen receptor modulator (SERM), has repeatedly demonstrated anticancer potential. In this study, we investigated whether RAL could induce apoptosis in GBM cells. Using rat C6 cells, we evaluated RAL's effects on cell viability, apoptosis induction, cell cycle progression, migration capacity, and colony formation, as well as on the gene and protein expression profiles of apoptosis-related signaling pathways. Our findings show that RAL significantly induces apoptosis and suppresses cell growth in a concentration- and time-dependent pattern compared to the vehicle control (0.1% DMSO). These findings would position RAL as a promising candidate for GBM therapy, warranting further investigation into its translational potential.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmacology and Toxicology, TeMS.C., Islamic Azad University, Tehran, Iran.
- Hearing Disorders Research Center, Loghman Hakim Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
- Department of Pharmacology and Toxicology, TeMS.C., Islamic Azad University, Tehran, Iran. Leila_mohaghegh@yahoo.com.
Zitieren
APA
Roustaei, M., Pournajaf, S., & Shalmani, L. M. (2026). Raloxifene suppresses growth and promotes intrinsic apoptotic signaling in C6 glioma cells. Naunyn-Schmiedeberg's Archives of Pharmacology. https://doi.org/10.1007/s00210-026-05792-x
Vancouver
Roustaei M, Pournajaf S, Shalmani LM. Raloxifene suppresses growth and promotes intrinsic apoptotic signaling in C6 glioma cells. Naunyn-Schmiedeberg's Archives of Pharmacology. 2026. doi:10.1007/s00210-026-05792-x
BibTeX
@article{Roustaei2026,
author = {Roustaei, Mahtab and Pournajaf, Safura and Shalmani, Leila Mohaghegh},
title = {Raloxifene suppresses growth and promotes intrinsic apoptotic signaling in C6 glioma cells},
journal = {Naunyn-Schmiedeberg's Archives of Pharmacology},
year = {2026},
doi = {10.1007/s00210-026-05792-x}
}
EUVIMED